New aspects of clinical and immunological characteristics in patients with anti-asparaginyl tRNA synthetase (anti-KS) autoantibody
Authors:
- 24 January 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 34 (1) , 122-128
Abstract
Objectives: Anti-asparaginyl tRNA synthetase (anti-KS) antibody is present in patients with interstitial lung disease (ILD) accompanied by polymyositis/dermatomyositis. We examined clinical/immunological features of these patients. Methods: Polymyositis/dermatomyositis or ILD patients were screened for autoantibodies, and clinical/immunological data were collected retrospectively. ILD was diagnosed by computed tomography, and clinical/immunological features of anti-KS-positive patients were compared with those of anti-Jo-1-positive patients. Results: Sixteen anti-KS-positive patients [female = 11; male = 5; average age 63.6 years (range, 40–81) years] were diagnosed: seven had ILD, four had clinically amyopathic DM (CADM) and ILD, three had Sjögren’s syndrome (SS) and ILD one each had rheumatoid arthritis and ILD, or CADM/SS overlap and ILD. All patients had ILD with chronic onset and clinical course; 11/16 (69%) had nonspecific interstitial pneumonia, and five (31%) had usual interstitial pneumonia pattern. Regarding skin manifestations, 4 (27%) had typical DM rash and 11 (69%) had mechanic’s hands. All anti-KS-positive patients had no clinical muscle weakness or serum creatine kinase elevation; 8/16 patients (50%) had sicca symptoms at a significantly high frequency compared with anti-Jo-1-positive patients (50% vs 11%, P = 0.01). Conclusions: Anti-KS-positive patients might form a distinguishable subset closely associated with sicca symptoms, CADM and chronic-type ILD with a relatively favourable prognosis.Keywords
This publication has 24 references indexed in Scilit:
- The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndromeAutoimmunity Reviews, 2014
- Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patientsAnnals of the Rheumatic Diseases, 2014
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the SyndromePLOS ONE, 2013
- Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significanceCurrent Opinion in Rheumatology, 2007
- Clinical and immunogenetic features of patients with autoantibodies to asparaginyl–transfer RNA synthetaseArthritis & Rheumatism, 2007
- In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung diseaseAutoimmunity, 2006
- Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 2002
- The Precipitating Antibody to an Acidic Nuclear Protein Antigen, the Jo‐1, in Connective Tissue DiseasesArthritis & Rheumatism, 1983
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975